CALB2 and lung adenocarcinoma: Similarly, using different dilutions of calretinin antibody (rabbit, Zymed, South San Francisco, CA) seemed to result in different calretinin positive rates in lung adenocarcinoma (8% versus 23%) [11,12,16].